About.

Contact.

Resources.

For The CEO.

For The HR Executive.

P: (111) 111-1111

E: something@something.com

providing innovative therapeutics

BioMarin

About BioMarin

BioMarin is a world leader

in developing and commercializing innovative biopharmaceuticals for rare diseases driven by genetic causes.

At BioMarin, we focus on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases. BioMarin remains steadfast to its original mission—to bring new treatments to market that will make a big impact on small patient populations.

Time is critical

to patients with rare diseases, and we strive to quickly develop important therapies for them. The efficiency and speed of our research, development, manufacturing, and commercial efforts is at the heart of our ability to urgently deliver therapies. Our track record of developing and commercializing new treatments has been significantly faster than the industry average and is ingrained in our culture.

Biopharmaceutical Company

Our success stems from our focus on science and the hope our therapies can bring to patients. We are world leaders in metabolic disease innovation with multiple products commercialized and a growing pipeline of product candidates to address unmet medical needs. We continue to fuel our R&D engine by looking for opportunities that align with our strengths and competencies.

BioMarin’s Culture

A constant in BioMarin’s culture is how patients continue to drive us. The passion and dedication that our employees bring to work each day is a testament to the inspiration our patients provide, and the knowledge of the impact we can make in their lives.

BIOMARIN PHARMACEUTICAL PARTNERS WITH WESTWOOD & WILSHIRE TO FILL DIRECTOR OF BUSINESS DEVELOPMENT

BioMarin, a biotechnology company focused on developing and commercializing innovative biopharmaceuticals for rare diseases, has hired Chieze Ibeneche-Nnewihe as the new Director of Business Development. Dr. Ibeneche-Nnewihe joins BioMarin from RA Capital Management, where she previously held progressively increasing levels of responsibility.

The search was successfully led by Chris Tillman for Westwood & Wilshire’s Life Sciences practice.

At Westwood & Wilshire, we recognize that people are an organization’s top asset. We are passionate about delivering premier talent to the world’s most innovative companies. We are particularly focused on companies ranging from VC-backed start-ups to mid-sized commercial entities and our assignments range from C-Suite to mid-management. Our firm has offices in Los Angeles, Silicon Valley, and Seattle, serving clients on a local, national and global basis.

Why Choose Us

WE BRING YOU LEADERS WHO SCALE COMPANIES

Our Life Sciences team partners with some of the most innovative companies on the planet across Biopharmaceuticals, Medical Device, Diagnostics and Digital Health.